We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MenQuadfi

News List

Sanofi’s meningococcal vaccine wins EU approval pharmatimes
November 25, 2020
French pharma company Sanofi has won approval from the European Commission (EC) for its meningococcal (MenACWY) vaccine MenQuadfi.
Sanofi’s meningococcal vaccine MenQuadfi secures FDA approval pharmaceutical-technology
April 30, 2020
Sanofi has received the US Food and Drug Administration (FDA) approval for its meningococcal conjugate vaccine, MenQuadfi.
US approves Sanofi's meningococcal vaccine pharmatimes
April 24, 2020
US regulators have issued a green light for Sanofi's meningococcal vaccine MenQuadfi for the prevention of invasive meningococcal disease in persons two years of age and older.